GlassScriptPhysician profile
Eric J Belin
NPI 1093859548
$41,444.91
in general payments reported to CMS, 2019-2025
14 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $33K · 2020: $217 · 2021: $1,393 · 2022: $48.68 · 2024: $7,000.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $7,000.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $7,000.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corelink, LLC | $26,500.33 | 2019 | |
| Xtant Medical INC | $7,000.00 | 2024 | |
| Nuvasive, INC. | $3,016.76 | 2019 | |
| Globus Medical, INC. | $1,076.29 | 2019 | |
| Alphatec Spine, INC | $1,051.99 | 2019 | |
| Seaspine Orthopedics Corporation | $1,000.00 | 2021 | |
| Medical Device Business Services, INC. | $678.41 | 2019 | |
| Medtronic USA, INC. | $415.28 | 2019-2020 | |
| Medtronic, INC. | $247.67 | 2021-2022 | |
| Surgalign Spine Technologies, INC. | $193.72 | 2021 | |
| Vertiflex, INC. | $129.06 | 2019 | |
| Integrity Implants INC. | $88.31 | 2019 | |
| Si-Bone, INC. | $24.46 | 2019 | |
| Orthofix Medical, INC. | $22.63 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Belin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.